Cohance Lifesciences P/E Ratio

COHANCE • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
46.02
High Valuation
Very High - High growth expectations or significantly overvalued

Current Valuation Metrics

P/E Ratio 46.02
Current Price ₹307.25
EPS (TTM) ₹10.52
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 54.6
Historical Range 20.06 - 152.93
Percentile 66.7%

Sector Context

Sector Average 47.17
Sector Median 25.62
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹7.34
Sept 2025 ₹1.94
Mar 2025 ₹3.16

Key P/E Ratio Insights for Cohance Lifesciences

  • Stock appears overvalued with PE of 46.02, suggesting caution for new investments

P/E Ratio Historical Trend for Cohance Lifesciences

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 152.93 7.34 ₹1122.50 NSE High
2024 61.41 11.73 ₹720.35 NSE High
2023 33.66 14.58 ₹490.75 NSE High
2022 33.09 14.88 ₹492.35 NSE High
2021 26.45 17.5 ₹462.85 NSE High
2020 20.06 16.8 ₹337.05 NSE Moderate

Sector P/E Ratio Comparison

Comparing Cohance Lifesciences with other companies in Healthcare sector
Sector Average
47.17
Sector Median
25.62
Lowest P/E
0.9
Highest P/E
898.7
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.9 ₹31 Low
Murae Organisor MURAE 2.86 ₹41 Low
Ind Swift Laboratories INDSWFTLAB 4.48 ₹1,128 Low
Amwill Health Care AMWILL 5.98 ₹61 Low
Medicamen Organics MEDIORG 6.37 ₹25 Low
Brooks Laboratories BROOKS 6.41 ₹127 Low
Unichem Laboratories UNICHEMLAB 7.14 ₹2,000 Low
Zenith Drugs ZENITHDRUG 7.28 ₹65 Low
Galaxy Medicare GML 7.77 ₹26 Low
Vasundhara Rasayans VRL 9.19 ₹34 Low